1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
AtriCure, Inc.

AtriCure, Inc.

ATRC
AtriCure, Inc.US flagNASDAQ Global Market
27.49
USD
+1.29
- -
1.39BMarket Cap

Total Valuation

AtriCure, Inc. carries a market capitalization of 1.39B, placing it among publicly traded companies globally. Its enterprise value stands at 1.31B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.39B
Enterprise Value1.31B

Share Statistics

AtriCure, Inc. currently has 50.63M shares outstanding.

Shares Outstanding50.63M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 2.50, and the price-to-book ratio stands at -3.34.

PE RatioN/A
PS Ratio2.50
PB Ratio-3.34
P/TBV Ratio6.53
P/FCF Ratio18.15
P/OCF Ratio21.45

Enterprise Valuation

On an enterprise value basis, AtriCure, Inc. trades at an EV/EBITDA multiple of 73.58 and an EV/FCF ratio of 15.50.

EV / Sales2.37
EV / EBITDA73.58
EV / EBITN/A
EV / FCF15.50

Financial Position

AtriCure, Inc. maintains a current ratio of 4.29, meaning it holds 4.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 14.60, indicating elevated leverage, while an interest coverage ratio of 3.06 demonstrates adequate ability to service its debt obligations.

Current Ratio4.29
Quick Ratio2.97
Debt / Equity14.60
Debt / EBITDA4.04
Interest Coverage3.06

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-0.74
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)-4.61
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.73

Taxes

Over the trailing twelve months, AtriCure, Inc. has paid 1.33M in income taxes, reflecting an effective tax rate of 98.18.

Income Tax1.33M
Effective Tax Rate98.18

Stock Price Statistics

AtriCure, Inc.'s stock has declined approximately -21.27721% over the past 52 weeks. The 50-day moving average sits at 28.28, while the 200-day moving average is 33.93.

Beta (5Y)N/A
52-Week Price Change-21.27721%
50-Day Moving Average28.28
200-Day Moving Average33.93
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, AtriCure, Inc. generated 552.16M in revenue and converted that into -4.59M in net income, yielding earnings per share of -0.09. EBITDA reached 17.75M, while operating income came in at -2.97M.

Revenue552.16M
Gross Profit417.46M
Operating Income-2.97M
Pretax Income-3.26M
Net Income-4.59M
EBITDA17.75M
EBIT-2.97M
Earnings Per Share (EPS)-0.09

Balance Sheet

AtriCure, Inc. holds 146.17M in cash and equivalents against 71.78M in total debt, resulting in a net debt position of -85.16M. Total book value stands at -413.04M, with working capital of 240.50M providing operational flexibility.

Cash & Cash Equivalents146.17M
Total Debt71.78M
Net Debt-85.16M
Equity (Book Value)-413.04M
Book Value Per Share-8.54
Working Capital240.50M

Cash Flow

AtriCure, Inc. produced 64.36M in operating cash flow over the past twelve months. After subtracting -11.72M in capital expenditures, free cash flow totaled 52.64M - equivalent to 1.09 per share.

Operating Cash Flow64.36M
Capital Expenditures-11.72M
Free Cash Flow52.64M
FCF Per Share1.09

Margins

AtriCure, Inc. operates with a gross margin of 75.61, reflecting its pricing power and cost economics. The operating margin of -0.54 and net profit margin of -0.83 provide insight into operational efficiency.

Gross Margin75.61
Operating Margin-0.54
Pretax Margin-0.59
Profit Margin-0.83
EBITDA Margin3.22

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield0.13
FCF Yield5.51

Scores

AtriCure, Inc. posts an Altman Z-Score of 6.13, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score6.13